Pricing Log in Create free account

Cabaletta Bio, Inc. (CABA) vs Korro Bio, Inc. (KRRO)

Cabaletta Bio, Inc. and Korro Bio, Inc. are both Biotechnology companies. Cabaletta Bio, Inc. is the larger, with a market value of $280.4M against $202.5M — 1.4× the size. Across the 9 metrics below, Korro Bio, Inc. leads on 6 and Cabaletta Bio, Inc. on 3.

Valuation

Metric CABA KRRO Biotechnology median
P/E n/m n/m 10.60
P/S n/m 40.65 9.40
P/B 0.93 2.52 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.16 n/m 0.66
EV/Sales n/m 25.53 9.02
Earnings yield (120.77%) (67.80%) (32.88%)
Free cash flow yield (78.96%) (26.27%) (23.13%)

Profitability

Metric CABA KRRO Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (93.20%) (97.69%) (51.96%)
Return on assets (75.36%) (62.03%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CABA KRRO Biotechnology median
Revenue growth (TTM) — (81.87%) 6.76%
EPS growth (last fiscal year) 10.26% (33.19%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CABA KRRO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.79 9.55 4.97
Net debt to EBITDA 0.84 0.64 1.01

Dividend

Metric CABA KRRO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CABA KRRO Biotechnology median
Market cap 280.44m 202.45m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack